ANVS Long Call Strategy
ANVS (Annovis Bio, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NYSE.
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
ANVS (Annovis Bio, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $33.8M, a beta of 1.19 versus the broader market, a 52-week range of 1.54-5.5, average daily share volume of 1.2M, a public-listing history dating back to 2020, approximately 8 full-time employees. These structural characteristics shape how ANVS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.19 places ANVS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on ANVS?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ANVS snapshot
As of June 30, 2026, spot at $1.85, ATM IV 32.64%, IV rank 5.30%, expected move 36.57%. The long call on ANVS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.
Why this long call structure on ANVS specifically: ANVS IV at 32.64% is on the cheap side of its 1-year range, which favors premium-buying structures like a ANVS long call, with a market-implied 1-standard-deviation move of approximately 36.57% (roughly $0.68 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ANVS expiries trade a higher absolute premium for lower per-day decay. Position sizing on ANVS should anchor to the underlying notional of $1.85 per share and to the trader's directional view on ANVS stock.
ANVS long call setup
The ANVS long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ANVS near $1.85, the first option leg uses a $1.85 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ANVS chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ANVS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.85 | N/A |
ANVS long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ANVS long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ANVS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ANVS
Long calls on ANVS express a bullish thesis with defined risk; traders use them ahead of ANVS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ANVS thesis for this long call
The market-implied 1-standard-deviation range for ANVS extends from approximately $1.17 on the downside to $2.53 on the upside. A ANVS long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ANVS IV rank near 5.30% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ANVS at 32.64%. As a Healthcare name, ANVS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ANVS-specific events.
ANVS long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ANVS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ANVS alongside the broader basket even when ANVS-specific fundamentals are unchanged. Long-premium structures like a long call on ANVS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ANVS chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ANVS?
- A long call on ANVS is the long call strategy applied to ANVS (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ANVS stock trading near $1.85, the strikes shown on this page are snapped to the nearest listed ANVS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ANVS long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ANVS long call priced from the end-of-day chain at a 30-day expiry (ATM IV 32.64%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ANVS long call?
- The breakeven for the ANVS long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ANVS market-implied 1-standard-deviation expected move is approximately 36.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ANVS?
- Long calls on ANVS express a bullish thesis with defined risk; traders use them ahead of ANVS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ANVS implied volatility affect this long call?
- ANVS ATM IV is at 32.64% with IV rank near 5.30%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.